Cancer-related anemia – diagnosis and treatment

Wojciech Pawlak; Marlena Wawrocka-Pawlak

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

9/2006
vol. 10

Send email

Copy url:

abstract:

Cancer-related anemia – diagnosis and treatment

Wojciech Pawlak

,

Marlena Wawrocka-Pawlak

Współcz Onkol (2006) vol. 10; 9 (475–484)

Online publish date: 2006/11/29

View full text Get citation

Cancer-related anemia is an important clinical factor in the treatment of malignant diseases. A correct approach to therapy should consider all the possible causes and patients need to be treated accordingly. Anemia negatively affects patients” quality of life, and is an adverse prognostic and predictive factor. Until the 1990s, transfusions as well as iron and vitamins repletion were the only treatment options for anemia. Over the last decade, clinical trials with epoetins have been conducted in a variety of settings in oncology. There are consistent evidences that administration of epoetins reduces the relative risk for blood transfusions and the number of blood units transfused in cancer patients. Moreover, epoetins significantly improve quality of life.

keywords:

Cancer-related anemia – diagnosis and treatment

Wojciech Pawlak , Marlena Wawrocka-Pawlak

cancer, anemia, erythropoietin, epoetin

Wojciech Pawlak

,

Marlena Wawrocka-Pawlak